Conservative group opposing PBM reform spends record lobbying sums; Novartis scolded again for marketing practices

Taking stock of the drug industry, from the lab to the medicine chest

July 18, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

GEORGE FREY/AFP via Getty Images STAT+ | Conservative group opposing PBM reform spends record number on lobbying A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. By Rachel Cohrs STAT+ | Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing Novartis was cited for making unsubstantiated and misleading claims in a podcast that promoted its best-selling Entresto heart failure drug. By Ed Silverman STAT+ | Johnson & Johnson sues to stop Medicare negotiation Johnson & Johnson is the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program. By Rachel Cohrs Adobe STAT+ | At Orexo, a 'turning point' for everything but digital health The Swedish pharmaceutical company Orexo notched several victors in Q2, but its digital health efforts are still struggling. By Mario Aguilar STAT+ | Flagship, Pfizer team up in deal worth up to $7 billion Pfizer and venture firm Flagship are joining forces to seek out new medicines in oncology, immunology, vaccines, and other disease areas. By Allison DeAngelis STAT Virtual Event: The State of Biosimilars: What to Watch STAT sits down with experts to discuss what's next for biosimilars, and what signals will indicate how they might be prescribed, or paid for. By Ed Silverman Adobe ARCH Venture Partners rises to the top of STAT's 2023 biotech VC rankings ARCH Venture Partners is no stranger to the top tiers of STAT's VC rankings, but this year it moved into first place. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser